Startup Genome comes to define premature scaling as “spending money beyond the essentials on growing the business (e.g., hiring sales personnel, expensive marketing, perfecting the product, leasing offices, etc.) before nailing the product/market fit.” After Starup Genome analyze surveys, they found that out 3,200 startup companies that fail, 70% failed because of premature scaling.
Read more at Forbes.com
2
SEP
SEP
About the Author